Auxo Firm Directory · Independent Research Profile

Conexus Capital Advisors

Conexus Capital Advisors provides sell-side and buy-side M&A advice, strategic and financial advisory, licensing and joint-venture advice, and related corporate transaction services. The firm states that it focuses on specialty ingredient industries and advises middle-market companies as well as some of the largest firms in those industries.

Key takeaway

Conexus Capital Advisors is an independent boutique M&A advisor focused on specialty ingredient industries.

Its public materials describe sell-side and buy-side advisory, a partner-led client-contact model, and transaction experience involving companies from North America, Europe, Latin America, and Asia Pacific.[1][2][3][4][5]

What does Conexus Capital Advisors do?

Conexus Capital Advisors is a globally oriented advisory firm founded in 2000 and headquartered in Miami, Florida, with an office in Cologne, Germany. It states that it advises middle-market companies as well as some of the largest firms in its specialty industries.[1][4]

Publicly stated services include sell-side and buy-side M&A advisory, strategic and financial advisory, licensing and joint ventures, shareholder buyouts and recapitalizations, financing or capital raising, and valuation opinions. The firm’s capabilities page specifically lists mergers and acquisitions, strategic and financial advisory, and licensing and joint-venture services.[1][2]

Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.

Public size / criteria information

Conexus states that it advises middle-market companies as well as some of the largest firms in its specialty industries. The cited capabilities page does not publish numeric minimum or maximum transaction-size, revenue, EBITDA, or standard fee criteria, and the cited industries page does not publish numeric client-size or transaction-size criteria.[4]

What should a business owner evaluate before hiring Conexus Capital Advisors?

For an owner considering a sale, the firm’s stated specialization covers flavors, fragrances, food ingredients, essential oils, aroma chemicals and white biology, and cosmetic ingredients. Its public materials also describe sell-side advisory, international transaction activity, and a partner-primary-contact model. An owner should confirm the engagement scope, fee structure, buyer-outreach process, conflicts policy, valuation methodology, and the partner who would lead the assignment.[1][2][3]

What transaction-size range does Conexus typically handle, and are there minimum revenue, EBITDA, or enterprise-value criteria

The cited capabilities page does not publish numeric minimum or maximum transaction-size, revenue, or EBITDA criteria, while the cited industries page does not publish numeric client-size or transaction-size criteria.[2][3]

What upfront, success, retainer, expense, tail, and termination fees would apply

The cited capabilities page does not publish a standard fee schedule.[2]

Which partner and team members would lead the engagement

Conexus states that a partner is the primary client contact and that projects are not turned over to subordinates after the first meeting.[2]

What size transactions and clients does Conexus Capital Advisors focus on?

Conexus identifies flavors and fragrances, food ingredients, essential oils, aroma chemicals and white biology, and cosmetic ingredients as target industries. The firm describes this as an exclusive focus on specialty ingredient industries.[1][3]

Huber the Nose: The Conexus transaction archive identifies Huber the Nose in a sell-side transaction marked as having been acquired. Flavorchem states that Huber the Nose is now part of Flavorchem & Orchidia Fragrances, and an external transaction report identifies Conexus Capital Advisors as Huber the Nose’s advisor.
Ecom Food Industries: Robertet announced the acquisition of Ecom Food Industries and stated that Conexus initiated the transaction and participated in the negotiations.
Quintessence Fragrances: Lucta states that Quintessence Fragrances joined the Lucta Group in 2024. Farrer & Co. states that Conexus provided M&A advice in connection with the sale to Lucta S.A.

[5][6][7][8][9]

The firm publicly describes sell-side and buy-side M&A advisory and other strategic corporate transaction advice. Its public transaction archive includes sell-side examples and transactions involving acquisitions, mergers, stake sales, division sales, and joint ventures.[1][2][5]

What does Conexus Capital Advisors publicly disclose about fees, process and engagement terms?

The cited Conexus transaction archive displays selected transaction examples and transaction-role labels but does not state transaction dates or deal values in the page text.

The cited capabilities page does not publish a numeric minimum or maximum transaction-size criterion, revenue threshold, EBITDA threshold, or standard fee schedule. The cited industries page identifies target industries and geographic regions but does not publish numeric client-size or transaction-size criteria.[2][3][5]

The Florida Division of Corporations lists CONEXUS CAPITAL ADVISORS, INC. as an active Florida profit corporation, document number P18000007955, with a principal address at 333 SE 2nd Ave, Miami, Florida. The corporate record lists Dietmar Hirt as president and registered agent.[10]

Conexus states that each client has a partner as the primary contact and that projects are not turned over to subordinates after the first meeting. Owners evaluating an engagement can ask the firm to identify the partner and team members who would lead the assignment.[2]

Questions to ask before hiring Conexus Capital Advisors

What transaction-size range does Conexus typically handle, and are there minimum revenue, EBITDA, or enterprise-value criteria?

What upfront, success, retainer, expense, tail, and termination fees would apply?

The cited capabilities page does not publish a standard fee schedule.[2]

Which partner and team members would lead the engagement?

Conexus states that a partner is the primary client contact and that projects are not turned over to subordinates after the first meeting.[2]

How are strategic buyers, private equity firms, and international buyers identified and screened?

Conexus states that its transaction record includes growth companies from North America, Europe, Latin America, and increasingly Asia Pacific; the buyer-identification and screening process is a matter for the owner to clarify.[3]

What conflicts exist with prior clients or current mandates in the same specialty-ingredient subsector?

The firm identifies a focused set of specialty ingredient industries, making its conflict-review approach a specific engagement point for an owner to clarify.[1][3]

Can the firm provide recent comparable transactions with dates, valuation ranges, and seller references?

The cited Conexus transaction archive displays selected examples and role labels but does not state transaction dates or deal values in the page text.[5]

What regulatory or legal-entity capacity applies to valuation opinions, capital raising, or securities-related services?

The Florida corporate record identifies Conexus Capital Advisors, Inc. as an active Florida profit corporation; the applicable capacity for particular services should be confirmed directly with the firm.[10]

Sources & research notes

Public-source research

Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.